A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
University Health Network, Toronto
University Health Network, Toronto
University of Southern California
City of Hope Medical Center
University of Southern California
University Hospital Plymouth NHS Trust
Instituto do Cancer do Estado de São Paulo
Universitätsklinikum Hamburg-Eppendorf
Asan Medical Center
Tianjin Medical University Cancer Institute and Hospital
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine